Processa Pharmaceuticals Inc. (PCSA)
NASDAQ · Healthcare
Processa Pharmaceuticals Inc. Shareholder Equity 2012–2022
Processa Pharmaceuticals Inc. annual shareholder equity history from 2012 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Processa Pharmaceuticals Inc. shareholder equity as of December 31, 2022: 7.5M, a 70.69% decrease year-over-year.
- Processa Pharmaceuticals Inc. shareholder equity for 2022 were 7.5M, a 70.69% decrease from 2021.
- Processa Pharmaceuticals Inc. shareholder equity for 2021 were 25.5M, a 1224.06% decrease from 2016.
- Processa Pharmaceuticals Inc. shareholder equity for 2016 were -2.3M, a 2545.39% increase from 2015.
- Processa Pharmaceuticals Inc. shareholder equity for 2015 were -85,705.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Processa Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $7 |
| 2021 | $25 |
| 2016 | $-2 |
| 2015 | $-0 |
| 2014 | $1 |
| 2013 | $2 |
| 2012 | $3 |
Processa Pharmaceuticals Inc. Shareholder Equity — FAQ
Processa Pharmaceuticals Inc. (PCSA) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCSA's shareholder equity history?
The chart and table above show Processa Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.